Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Shire    SHP   JE00B2QKY057

SHIRE (SHP)
My previous session
Most popular
  Report  
Real-time Quote. Real-time Cboe Europe - 10/18 05:30:00 pm
4518.5 GBp   +1.21%
04:53pSHIRE : Form 8.3 - SHIRE PLC - AMENDMENT
PU
04:08pSHIRE : Form 8.5 (EPT/RI) - Replacement of SHIRE
PU
01:16pSHIRE : Notice Of Results
DJ
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsTweets

Shire plc Shire Plc : Block Listing Interim Review -2-

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/24/2017 | 04:16pm CEST
Balance of unallotted securities under scheme(s) from 
 previous return:                                                                        769,615 
Plus: The amount by which the block scheme(s) has 
 been increased since the date of the last return (if 
 any increase has been applied for):                                                         Nil 
Less: Number of securities issued/allotted under scheme(s) 
 during period (see LR3.5.7G):                                                           408,873 
Equals: Balance under scheme(s) not yet issued/allotted 
 at end of period:                                                                       360,742 
 
 
 
 
 
 
 
Name of applicant:                                              Shire plc 
                                                                Shire Employee Stock Purchase 
Name of scheme:                                                 Plan 
                                                                November 23, 
Period of return:                     From:                     2016           To:  May 22, 2017 
Balance of unallotted securities under scheme(s) from 
 previous return:                                                                        244,057 
Plus: The amount by which the block scheme(s) has 
 been increased since the date of the last return (if 
 any increase has been applied for):                                                         Nil 
Less: Number of securities issued/allotted under scheme(s) 
 during period (see LR3.5.7G):                                                             6,359 
Equals: Balance under scheme(s) not yet issued/allotted 
 at end of period:                                                                       237,698 
 
 
 
 
Name of applicant:                                              Shire plc 
                                                                Shire Long Term Incentive Plan 
Name of scheme:                                                 2015 
                                                                November 23, 
Period of return:                     From:                     2016          To:  May 22, 2017 
Balance of unallotted securities under scheme(s) from 
 previous return:                                                                      2,836,412 
Plus: The amount by which the block scheme(s) has 
 been increased since the date of the last return (if 
 any increase has been applied for):                                                         Nil 
Less: Number of securities issued/allotted under scheme(s) 
 during period (see LR3.5.7G):                                                           149,340 
Equals: Balance under scheme(s) not yet issued/allotted 
 at end of period:                                                                     2,687,072 
 
 
 
 
Name of applicant:                                              Shire plc 
                                                                Shire Global Employee Stock 
Name of scheme:                                                 Purchase Plan 
                                                                November 23, 
Period of return:                     From:                     2016          To:   May 22, 2017 
Balance of unallotted securities under scheme(s) from 
 previous return:                                                                      1,604,243 
Plus: The amount by which the block scheme(s) has 
 been increased since the date of the last return (if 
 any increase has been applied for):                                                         Nil 
Less: Number of securities issued/allotted under scheme(s) 
 during period (see LR3.5.7G):                                                             3,400 
Equals: Balance under scheme(s) not yet issued/allotted 
 at end of period:                                                                     1,600,843 
 
 
 
 
Name of applicant:                                              Shire plc 
Name of scheme:                                                 Baxalta Exchange Awards 
                                                                November 23, 
Period of return:                     From:                     2016           To:  May 22, 2017 
Balance of unallotted securities under scheme(s) from 
 previous return:                                                                     20,488,204 
Plus: The amount by which the block scheme(s) has 
 been increased since the date of the last return (if 
 any increase has been applied for):                                                         Nil 
Less: Number of securities issued/allotted under scheme(s) 
 during period (see LR3.5.7G):                                                         2,492,337 
Equals: Balance under scheme(s) not yet issued/allotted 
 at end of period:                                                                    17,995,867 
 
 
 
 
Name of contact:               Sarah Rixon, Company Secretarial Assistant 
Telephone number of contact:                                 01256 894000 
 
 
   For further information please contact: 
 
 
 
 
Investor Relations 
Ian Karp             ikarp@shire.com         +1 781 482 9018 
Robert Coates        rcoates@shire.com      +44 203 549 0874 
Media 
Lisa Adler           lisa.adler@shire.com    +1 617 588 8607 
Katie Joyce          kjoyce@shire.com        +1 781 482 2779 
 
 
   NOTES TO EDITORS 
 
   About Shire 
 
   Shire is the global leader in serving patients with rare diseases. We 
strive to develop best-in-class therapies across a core of rare disease 
areas including hematology, immunology, genetic diseases, neuroscience, 
and internal medicine with growing therapeutic areas in ophthalmics and 
oncology. Our diversified capabilities enable us to reach patients in 
more than 100 countries who are struggling to live their lives to the 
fullest. 
 
   We feel a strong sense of urgency to address unmet medical needs and 
work tirelessly to improve people's lives with medicines that have a 
meaningful impact on patients and all who support them on their journey. 
 
   www.shire.com 
 
   This announcement is distributed by Nasdaq Corporate Solutions on behalf 
of Nasdaq Corporate Solutions clients. 
 
   The issuer of this announcement warrants that they are solely 
responsible for the content, accuracy and originality of the information 
contained therein. 
 
   Source: Shire plc via Globenewswire 
 
 
 
 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on SHIRE
06:41pTAKEDA PHARMACEUTICAL : Japan’s Takeda gets regulator’s approval to ..
AQ
04:53pSHIRE : Form 8.3 - SHIRE PLC - AMENDMENT
PU
04:08pSHIRE : Form 8.5 (EPT/RI) - Replacement of SHIRE
PU
01:16pSHIRE : Notice Of Results
DJ
01:13pSHIRE : to announce third quarter 2018 results
PU
12:43pSHIRE : Form 8.3 - Shire
PU
12:33pSHIRE : Form 8.5 - Shire plc
PU
10:33aTAKEDA PHARMACEUTICAL : gets Japanese approval for $62 billion Shire purchase
RE
09:58aSHIRE : Form 8.3 - Takeda Pharmaceutical Company Limited
PU
09:03aSHIRE : Statement regarding Japan Clearance
PU
More news
News from SeekingAlpha
07:57aMarkets Under Pressure Over Future Fed Hikes (Wall Street Breakfast Podcast) 
07:01aWALL STREET BREAKFAST : Fed Maintains Hawkish Tone 
03:37aTakeda gets Shire clearance from Japan 
10/16Ad Com October 18 for Shire's constipation med prucalopride 
10/16Merger Arbitrage Mondays - October 15, 2018